Interest in TCM growing globally

More than 100 countries and regions around the world have set up TCM institutions, with the United States , Europe, Japan and South Korea investing heavily in related research and medication development, industry, analyses show.

According to Xinhuanet, the UK-based pharmaceutical company GlaxoSmithKline PLC announced its first TCM medication research and development program, which targets not just the Chinese market, but the global one as well.

"TCM is a well-established medical science based on thousands of years of clinical practices. It shows great promise treating complicated conditions that the single-target Western medicine has failed to handle," said Zang Jingwu, senior vice-president and head of GlaxoSmithKline's R&D in China.

Read full story